InvestorsHub Logo
icon url

ignatiusrielly35

02/27/17 3:49 PM

#14029 RE: hdwrsft #14028

Can think of no reason that a lawsuit about alleged misrepresentation of a clinical timeline would affect AT-104's approval.
icon url

gajj

02/27/17 6:45 PM

#14053 RE: hdwrsft #14028

been arguing for months that Advaxis should sue Aratana. Aratana's inability to perform has cost Advaxis and its shareholders revenue and market price